Nebulized fentanyl for respiratory symptoms in patients with COVID-19 (ventanyl trial)

Patients with coronavirus disease (COVID-19) commonly experience distressing and challenging respiratory symptoms. Interventions such as oxygen therapy, oral opiates, and traditional nebulizers like ipratropium bromide and salbutamol are variable in their efficacy, and therapy responses in patients...

Descripción completa

Detalles Bibliográficos
Autores principales: Shaikh, Nissar, Khatib, Mohamad Y., Wraidat, Mohammad A. Al, Mohamed, Ahmed S., Al-Assaf, Anood A., Tharayil, Abdul Gafoor M., Abujaber, Ahmad A., Nashwan, Abdulqadir J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2022
Materias:
3900
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8797561/
https://www.ncbi.nlm.nih.gov/pubmed/35089202
http://dx.doi.org/10.1097/MD.0000000000028637

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8797561/
https://www.ncbi.nlm.nih.gov/pubmed/35089202
http://dx.doi.org/10.1097/MD.0000000000028637

Ejemplares similares